As of November 6, 2026, Psyence Biomedical Ltd. is a publicly traded company (Nasdaq: PBM). The largest holder reporting an active stake on Schedule 13D is Psyence Labs Ltd., at 49.75%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include AdvisorShares Trust (6.78%) (Schedule 13D/A, October 15, 2026).
Is this your company?
About to sign with, pay or invest in Psyence Biomedical Ltd.? See the free Snapshot first.
Free to see. No signup.
Is Psyence Biomedical Ltd. a real, registered company?
- Psyence Biomedical LTD. files with the SEC under CIK 1985062 (its SEC filings).
- Its shares are listed under the ticker PBM on Nasdaq (also PBMWW) (SEC company record).
- Incorporated in A6, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under PSYENCE BIOMEDICAL LTD. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Psyence Labs Ltd. (filed 2026-10-15).
Who are Psyence Biomedical Ltd.'s owners and officers?
Psyence Biomedical Ltd.: industry Pharmaceutical Preparations (Schedule 13D/A, 2026-10-15).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-01-07)
- : Executive Officer, Director (Form D, 2025-01-07)
- : Executive Officer (Form D, 2025-01-07)
- : Director (Form D, 2025-01-07)
- : Director (Form D, 2025-01-07)
- : Director (Form D, 2025-01-07)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-10-15 | Psyence Labs LTD. | 49.75% |
| Schedule 13G, 2026-10-05 | Advisorshares Trust | 6.78% |
| Schedule 13G/A, 2026-06-10 | Weiner Jeffrey David | 2.61% |
| Schedule 13D, 2026-06-03 | Psyence Labs LTD. | 30.05% |
| Schedule 13G, 2026-02-19 | Weiner Jeffrey David | 5.07% |
| Schedule 13D/A, 2026-01-13 | Kaos Capital LTD. | 4.91% |
| Schedule 13D, 2025-12-10 | Kaos Capital LTD. | 16.77% |
Questions about who owns Psyence Biomedical Ltd.
Who owns Psyence Biomedical Ltd.?
On this page, 2 holders' latest ownership filings report 5% or more of Psyence Biomedical Ltd.: Psyence Labs LTD. (49.75%, Schedule 13D/A, filed 2026-10-15) and Advisorshares Trust (6.78%, Schedule 13G, filed 2026-10-05).
Who are the largest shareholders of Psyence Biomedical Ltd.?
By the share each holder's latest filing reports, the largest holders of Psyence Biomedical Ltd. on this page are Psyence Labs LTD. (49.75%) and Advisorshares Trust (6.78%).
When did Psyence Labs LTD. buy into Psyence Biomedical Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Psyence Labs LTD. on this page is the Schedule 13D, filed 2026-06-03, reporting 30.05%; its latest, Schedule 13D/A filed 2026-10-15, reports 49.75%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Psyence Biomedical Ltd.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Psyence Biomedical Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Psyence Biomedical Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
How much has Psyence Biomedical Ltd. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-01-07 | $2M | $2M |
Latest IPO step: Psyence Biomedical Ltd. amended its IPO registration (F-1/A, 2025-10-14).
IPO filings: F-1/A, 2025-10-14, F-1/A, 2025-10-06, F-1, 2025-01-24, F-1, 2024-12-20, F-1, 2024-10-30; ticker PBM on Nasdaq Capital Market.
Keep reading
More on Psyence Biomedical Ltd. and the records around it.
Psyence Biomedical Ltd. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- AdvisorShares Trust also filed stake reports on 8 other companies: Neuphoria Therapeutics Inc. (Oct 2026), Silo Pharma, Inc. (Jul 2026), Enveric Biosciences, Inc. (Jan 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/psyence-biomedical